Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
Mereo BioPharma Group plc (MREO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
As of 11:28AM EDT. Market open.
Mountain
Settings
- Zacks
MEREO BIOPHARMA (MREO) Loses -12.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 10:15am ET / 03:15pm BST. A live audio webcast of the presentation can be accessed through the Investors section of the Compa
- GuruFocus.com
Mereo BioPharma Group PLC (MREO) Announces Full Year 2023 Financial Results
Setrusumab and Alvelestat Progress as Company Prepares for Transformative 2024
Advertisement
Advertisement
Advertisement